HB 1962 Missouri House · 2026 Regular Session

Modifies provisions relating to limits on selling or purchasing certain drugs

HB 1962 modifies Missouri's limits on selling or purchasing drugs containing ephedrine, phenylpropanolamine, or pseudoephedrine (common in cold medications). It sets specific daily, monthly, and annual purchase limits: 3.6 grams per 24 hours, 7.2 grams per 30 days, and 61.2 grams per year for the same individual. The bill requires these drugs to be sold only behind pharmacy counters by licensed staff and mandates pharmacies to report sales to a tracking system. It directly affects pharmacies, pharmacists, and individuals purchasing these specific drug products.

Bill status in committee 1 of 4 stages cleared

Introduction

Dec 2025

Committee Review

Floor Vote

Governor

Introduced Dec 1, 2025 Last action Mar 26, 2026

Maddy AI version diff · 1 comparison

What changed between versions

Introduced → House Committee Substitute · 3 edits

MINOR

The bill was amended from an Introduced version to a House Committee Substitute version, primarily changing the bill identifier from HB 1962 to HCS HB 1962 and updating the clerk's reference number. The substantive policy content regarding drug sales limits and tracking requirements remains unchanged, with no new restrictions, exemptions, or timeline adjustments introduced in this revision.

TECHNICAL

Bill identifier changed from HB 1962 to HCS HB 1962 to reflect House Committee Substitute status

Clerk reference number updated from 4028H.01I to 4028H.02C

Minor formatting adjustments to line numbering and spacing throughout the document

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 26, 2026

Lower · Passed

HCS Reported Do Pass (H) - AYES: 16 NOES: 0 PRESENT: 0

lower

Mar 26, 2026

Lower · Passed

HCS Voted Do Pass (H)

lower

Feb 26, 2026

Committee

Referred: Health and Mental Health(H)

lower

Dec 1, 2025

Introduced

Prefiled (H)

lower

1 primary · 0 co-sponsors